Effect of Inhaled Volatile and IV Anesthetics on Biological Markers of Inflammation in Adult ICU and Thoracic Surgical Patients: A Systematic Review and Meta-Analysis
- PMID: 40637441
- PMCID: PMC12440536
- DOI: 10.1097/CCE.0000000000001280
Effect of Inhaled Volatile and IV Anesthetics on Biological Markers of Inflammation in Adult ICU and Thoracic Surgical Patients: A Systematic Review and Meta-Analysis
Abstract
Objectives: Inhaled anesthetics may reduce alveolar and systemic inflammation in surgical and critically ill patients. This study aimed to perform a systematic review and meta-analysis comparing the effect of inhaled volatile and IV anesthetics on alveolar and plasma cytokines in patients with surgical or medical acute lung injury.
Data sources: Medline, Embase, and Cochrane CENTRAL databases from 2000 to July 2021.
Study selection: Randomized control trials, prospective, and retrospective observational studies comparing inhaled volatile to IV anesthetics in ventilated adult patients with acute lung injury from lung resection or critical illness.
Data extraction: A systematic review and meta-analysis was performed. Primary outcome was alveolar inflammatory cytokines levels that were meta-analyzed using a random effects model. Secondary outcomes were plasma inflammatory cytokine levels, mortality, pulmonary complications, and duration of hospital and ICU stay. The quality of studies was assessed using the Cochrane Risk of Bias tool for randomized control trials and the Cochrane Risk Of Bias In Non-randomized Studies of Interventions tool for retrospective cohort studies.
Data synthesis: From 2522 screened studies, 28 (27 thoracic surgery and 1 ICU, n = 4175) were included. Meta-analysis of patients undergoing lung resection demonstrated lower levels of alveolar tumor necrosis factor-alpha (TNF-α) (standard mean difference 1.04; 95% CI, 0.32-1.77; p < 0.01; I2 82%) and interleukin (IL)-6 (0.64; 95% CI, 0.52-0.75; I2 0%; p < 0.01) at 1-2 hours in the inhaled anesthesia group, with no difference in other cytokines at various time points. The single ICU study demonstrated lower plasma TNF-α and IL-6 and alveolar TNF-α, IL-6, and IL-8 at 48 hours in patients sedated with sevoflurane compared with midazolam. Clinical outcomes were infrequently reported.
Conclusions: Limited evidence suggests that inhaled anesthesia may reduce proinflammatory cytokines TNF-α and IL-6 during lung resection and critical illness. Further studies are needed to clarify its effects on biological markers and clinical outcomes.
Keywords: critical care; cytokine; inflammation; lung injury; lung resection; one-lung ventilation; thoracic surgery; volatile anesthetics.
Copyright © 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Conflict of interest statement
Drs. Jerath and Cuthbertson are supported by the Merit Award, Department of Anesthesiology and Pain Medicine, University of Toronto. Drs. Jerath, Slessarev, and Cuthbertson have received grant funding from the Canadian Institute of Health Research and the Ontario Government. Drs. Jerath and Cuthbertson received funding from Alternate Funding Plan, Ministry of Ontario. Drs. Jerath, Slessarev, and Cuthbertson received funding Government of Ontario. Drs. Slessarev and Jerath have an ongoing clinical trial examining the effects of inhaled anesthetics on cognitive outcomes in critically ill adult patients. Dr. Leligdowicz is a recipient of the Wolfe-Western Fellowship award.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources